SYMPLICITY HTN-3 results to be announced:a mystery or a story foretold?

被引：0
|
作者：
Jan A Staessen [1 ,2 ]
Yu Jin [1 ,2 ]
Alexandre Persu [3 ,4 ]
机构：
[1] Research Unit Hypertension and Cardiovascular Epidemiology,KU Leuven
[2] Department of Cardiovascular Sciences,University of Leuven
[3] Pole of Cardiovascular Research,Institut de Recherche Experimentale et Clinique,Universite Catholique de Louvain
[4] Division of Cardiology,Cliniques Universitaires Saint-Luc,Universite Catholique de Louvain
来源：
The Journal of Biomedical Research | 2014年 / 28卷 / 02期
关键词：
RDN; HTN; SYMPLICITY HTN-3 results to be announced;
D O I：
暂无
中图分类号：
R544.1 [高血压];
学科分类号：
1002 ; 100201 ;
摘要：
The SYMPLICITY HTN-1;and HTN-2 studies;showed that renal denervation（RDN）is feasible as a novel treatment for resistant hypertension.Despite great enthusiasm toward this new treatment modality;,until now the current evidence rests on only one randomized controlled trial;.SYMPLICITY HTN-3;is a pivotal study started for regulatory purposes in the United States with the goal to evaluate the efficacy and safety of RDN in treatment of resistant hypertension.It is a randomized trial including 535 resistant hypertensive patients randomized to RDN or control（sham）in a ratio of 2:1.On 9 January 2014,Medtronic announced that SYMPLICITY HTN-3 failed to
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [1] SYMPLICITY HTN-3 results to be announced: a mystery or a story foretold?
    Staessen, Jan A.
    Jin, Yu
    Persu, Alexandre
    [J]. JOURNAL OF BIOMEDICAL RESEARCH, 2014, 28 (02): : 73 - 74
  • [2] Symplicity HTN-3 studio
    Taddei, Stefano
    Trabattoni, Daniela
    [J]. GIORNALE ITALIANO DI CARDIOLOGIA, 2014, 15 (09) : 460 - 464
  • [3] SYMPLICITY HTN-3 study
    Radziemski, Artur
    Kostka-Jeziorny, Katarzyna
    [J]. ARTERIAL HYPERTENSION, 2014, 18 (02): : 51 - 55
  • [4] SYMPLICITY HTN-3 Study COMMENT
    Tykarski, Andrzej
    Grajek, Stefan
    [J]. ARTERIAL HYPERTENSION, 2014, 18 (02): : 56 - 58
  • [5] Was there real denervation in the SYMPLICITY HTN-3 trial?
    Ruilope, Luis M.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (26) : 1699 - 1700
  • [6] New analysis of the SYMPLICITY HTN-3 trial
    Mason, E.
    Tofield, A.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (09) : 535 - 535
  • [7] SYMPLICITY HTN-3 screen failure patient cohort
    Waksman, R.
    Bakris, G. L.
    Steinvil, A.
    Garcia-Garcia, H. M.
    Debruin, V.
    Jolivette, D.
    Jones, D.
    Bhatt, D. L.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 230 - 230
  • [8] Current Brief Comment: SYMPLICITY HTN-3: No Surprise?
    Slany, J.
    [J]. JOURNAL FUR HYPERTONIE, 2014, 18 (01): : 19 - 21
  • [9] Renal sympathetic denervation in the aftermath of Symplicity HTN-3
    Kjeldsen, Sverre E.
    Elmula, Fadl E. M. Fadl
    Persu, Alexandre
    Jin, Yu
    Staessen, Jan A.
    [J]. BLOOD PRESSURE, 2014, 23 (05) : 256 - 261
  • [10] Renal Denervation after Symplicity HTN-3: An Update
    Alexandre Persu
    Yu Jin
    Fadl Elmula Mohamed Fadl Elmula
    Lotte Jacobs
    Jean Renkin
    Sverre Kjeldsen
    [J]. Current Hypertension Reports, 2014, 16
12345